PA
IMGO

Perceptive Advisors’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Perceptive Advisors’s Portfolio IMGO Stock Details IMGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-125,000
Closed -$2.5M – 160
2021
Q3 		$2.5M Buy
+125,000
New +$2.68M 0.04% 130

Other funds holding IMGO

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Perceptive Advisors's IMGO Position: Q4 2021 in Review

Perceptive Advisors sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q4 2021, closing a stake of 125,000 shares — an estimated $2.5M sold.

Perceptive Advisors first reported a position in IMGO in Q3 2021 and held it in 1 quarter. The position peaked at $2.5M in Q3 2021. 52 funds tracked by Wall St. Rank hold IMGO as of Q4 2021.

  • Perceptive Advisors reported no remaining Imago BioSciences, Inc. Common stock position as of Q4 2021 after selling out during the quarter.
  • Perceptive Advisors sold 125,000 Imago BioSciences, Inc. Common stock shares in Q4 2021, an estimated $2.5M.
  • Perceptive Advisors first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 1 quarter.
  • Perceptive Advisors's Imago BioSciences, Inc. Common stock position peaked at $2.5M in Q3 2021.
  • 52 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q4 2021.

Based on Perceptive Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.